Related Experiment Video
Updated: Jul 8, 2026
05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Should levodopa dose be reduced when switched to stalevo?
G Linazasoro1, J Kulisevsky, B Hernández
1Centro Investigación Parkinson, Policlínica Gipuzkoa, San Sebastián, Spain. glinazasoro@terra.es
European Journal of Neurology
|January 25, 2008
Summary
Switching Parkinson's patients to levodopa-carbidopa-entacapone (LCE) effectively manages wearing-off. Maintaining the original levodopa-carbidopa (LC) dosage is often practical and safe, even with mild dyskinesias.
Area of Science:
- Neurology
- Pharmacology
Background:
- Parkinson's disease (PD) management often involves levodopa-carbidopa (LC).
- Wearing-off phenomenon and dyskinesias are common challenges in PD treatment.
- Entacapone addition or switching to levodopa-carbidopa-entacapone (LCE) can improve motor fluctuations but may increase dyskinesias.
Purpose of the Study:
- To determine the optimal strategy for switching PD patients from LC to LCE.
- To evaluate efficacy, tolerability, and safety of switching, with or without levodopa dose reduction.
- To address the balance between managing wearing-off and minimizing dyskinesia exacerbation.
Main Methods:
- A clinical trial involving 39 patients with PD experiencing wearing-off.
- Random assignment to two groups: maintaining LC dosage or reducing LC dosage by 15-25%.
- Assessment of 'on' time, 'off' time, and dyskinesia occurrence over four weeks.
Main Results:
- Both groups demonstrated increased 'on' time and reduced 'off' time.
- No significant clinical differences were observed between the groups.
- Two patients in each group experienced an increase in basal dyskinesias; overall tolerance was excellent.
Conclusions:
- Switching from LC to LCE is safe and effective for mild-to-moderate wearing-off in PD.
- Reducing levodopa dosage is not always necessary and may impact efficacy.
- Maintaining the current LC dosage during the switch is a practical approach unless severe dyskinesias are present.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...